151 results on '"Bouleuc C"'
Search Results
2. Palliative care integration and end-of-life care intensity for patients with NSCLC
3. Could palliative sedation be seen as unnamed euthanasia?: a survey among healthcare professionals in oncology
4. In the digital health era, collegiality as an ethical resource against healthcare professionals’ loneliness
5. Les nouveaux outils digitaux de soins de support pour les patients atteints de cancer du poumon: New digital tools for supportive care for lung cancer patients
6. Soins palliatifs oncologiques précoces : de quoi parle-t-on ?
7. Comment intégrer de manière précoce les soins palliatifs pour les patients atteints de cancer bronchique ?
8. Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial
9. Définir les soins de support : une contribution philosophique
10. 2054P Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
11. 2031O Randomized trial of a telephone-based weight loss intervention in overweight and obese patients (pts) with breast cancer (BC): The MEDEA trial
12. La décision d’arrêt de la chimiothérapie chez les patientes atteintes de cancer du sein métastatique
13. Limites subjectives de la prise en charge des patientes métastatiques. Quand les traitements oncostatiques laissent la place aux traitements palliatifs
14. Palliative care delivery according to age among metastatic breast cancer patients. ESME-MBC cohort
15. Gemcitabine Combined With Oxaliplatin in Advanced Pancreatic Adenocarcinoma: Final Results of a GERCOR Multicenter Phase II Study
16. Die Kombination Gemcitabin-Oxaliplatin (GEMOX) bei fortgeschrittenem Pankreaskarzinom (APC): Eine multizentrische Phase-II-Studie (GERCOR): 506
17. Impact de la nutrition parentérale chez des patients atteints d’un cancer en situation avancée : essai clinique randomisé de phase IV
18. Facteurs d’accès aux prises en charge palliatives interdisciplinaires des patients atteints de cancer du sein métastatique de la cohorte ESME-CSM : analyse préliminaire
19. L’anticipation palliative : pourquoi et pour quoi ?
20. Validation de l’outil EPA® chez les patients en phase palliative d’un cancer : résultats de l’étude ALIM-K
21. Abstract P2-11-16: Prospective comparison of prognostic factors in patients starting a third line of chemotherapy for metastatic breast cancer: An ancillary study to the CirCe01 trial
22. Comment améliorer la satisfaction des patients sur l'information médicale en cancérologie ?
23. La décision d'arrêt de chimiothérapie pour les patients atteints de cancer du sein métastatique
24. Does a Geriatric Oncology Consultation Modify the Cancer Treatment Plan for Elderly Patients?
25. P051 Décisions d’arrêt de la nutrition artificielle en fin de vie chez les patients d’onco-hématologie
26. 15 Use of a geriatric assessment questionnaire for older patients in an oncology clinic. Descriptive study of 105 patients at the Institut Curie, a French cancer treatment center
27. Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma. Preliminary results
28. Impact of American Society of Clinical Oncology Guidelines for Clinical Use of Colony-Stimulating Factors
29. Anémie hémolytique microangiopathique associée à un sarcome utérin : rapport d'un cas. Revue de la littérature
30. Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma
31. Intensification thérapeutique et autotransplantation de cellules-souches hématopoïétiques dans le traitement des tumeurs solides de l'adulte. Principes, réalisation et application au traitement des tumeurs germinales, trophoblastiques, mammaires, ovariennes et bronchiques à petites cellules. 2e partie
32. Intensification thérapeutique et autotransplantation de cellules-souches hématopoïétiques dans le traitement des tumeurs solides de l'adulte : principes, réalisation et application au traitement des tumeurs germinales, trophoblastiques, mammaires, ovariennes et bronchiques à petites cellules. Première partie
33. Phase II trial of 5-fluoro-uracil (5FU), folinic acid (FA) and cisplatinum (CDDP) in the treatment of pancreatic adenocarcinoma
34. Tandem high-dose (HD) chemotherapy (CT) with VM-26, ifosfamide (IFM), and carboplatin (CBDCA) with autologous bone marrow transplantation (ABMT) for patients with stage IIIC-IV ovarian cancer (OC)
35. High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
36. The relationship between introduction of American Society of Clinical Oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris University Hospital
37. Case report: uterus sarcoma associated with a microangiopathic hemolytic anemia
38. Anticancer drugs off label used of: What do the experts think about? | Prescriptions hors AMM en cancérologie: Qu'en pensent les experts?
39. The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease
40. [Therapeutic intensification and autotransplantation of hematopoietic stem cells in metastatic breast cancers]
41. [High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors]
42. Treatment of unresectable hepatocellular carcinoma with a combination of human recombinant α-2b interferon and doxorubicin: Results of a pilot study
43. Intensification thérapeutique et autotransplantation de cellules-souches hématopoïétiques dans le traitement des tumeurs solides de l'adulte. Principes, réalisation et application au traitement des tumeurs germinales, trophoblastiques, mammaires, ovariennes et bronchiques à petites cellules. 2 e partie
44. High-dose chemotherapy and autologous stem cell support for the treatment of solid tumors in adults. 2nd part
45. High-dose chemotherapy and autologous stem cell support for the treatment of solid tumors in adults. First part
46. Prevalence and survival implications of malnutrition and sarcopenia in metastatic breast cancer: A longitudinal analysis.
47. [The future law on "assisted dying" in France: Where are we going?]
48. Palliative Care Interventions and End-of-Life Care for Patients with Metastatic Breast Cancer: A Multicentre Analysis.
49. Oncologists' perspective on advance directives, a French national prospective cross-sectional survey - the ADORE study.
50. [A 2023 inventory in oncology news].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.